Background: We report a rare case of carcinoma in situ (CIS) in conjunction with a primary pterygium that exhibited characteristic angiographic and histopathological findings. Case: A 78-year-old man presented with a pterygium and a whitish tumor adjacent to the pterygium in his right eye. Indocyanine green angiography displayed that feeder vessels within the primary pterygium spread to the whitish tumor. The tumor and pterygial tissues were surgically removed. Histologically, the resected tissue contained CIS as well as squamous metaplasia. There was a marked inflammatory cell infiltration within the tumor and beneath the epithelium. Topical interferon alfa-2b was given 4 times per day for 2 months. The patient has been well without local recurrence of tumor or distal metastases to 54 follow-up months after surgery. Conclusions: Because CIS can occur adjacent to pterygial tissues, long-term followup is necessary in patients with pterygia.
Introduction
Conjunctival intraepithelial neoplasia contains dysplasia and carcinoma in situ (CIS) [1] . Ultraviolet rays and infections with viruses such as human papillomavirus and human im-munodeficiency virus play an important role in the pathogenesis of conjunctival epithelial malignancies [2] [3] [4] . Pterygium is an invasion of the cornea by proliferation of abnormal (sub)conjunctival tissues together with a chronic inflammatory reaction. Conjunctival epithelial malignancy has a close relation to pterygium because of the fact that various proteins are expressed similarly in both epithelial cells [5] and CIS can coexist with pterygium [6] . However, there are no reports showing evidence that CIS is possibly arising from a primary pterygium itself or the adjacent tissue.
We herein report a rare case of CIS in conjunction with primary pterygium that exhibited characteristic angiographic and histopathological findings of inflammatory cell infiltration.
Case Report
A 78-year-old man presented with a conjunctival nodule in his right eye. He had a medical history of diabetes, hypertension, and cerebral hemorrhage. He has been under observation due to cataract and glaucoma by a nearby ophthalmologist from February 2012. In July 2012, slit lamp examination of the right eye revealed a primary nasal pterygium progressing to the cornea. Four months later, an elevated lesion was noted at the upper side of the pterygium. Since the elevated lesion became thicker with a rough surface and developed to the cornea, he was referred to our department on The whitish nodule was clinically diagnosed as CIS adjacent to a primary pterygium. Both lesions were resected with a safety margin (measuring 3 mm), which was reconstructed using a conjunctival rotation flap on March 21, 2013. Histological findings of the tissue surgically removed were CIS as well as squamous metaplasia ( fig. 2a, asterisks) . In addition, there was an aggregation of plenty of lymphocytes forming lymphoid follicles beneath the epithelium ( fig. 2a, arrows) . At high magnification, neutrophil infiltration was markedly found to be present within the carcinomatous tissue ( fig. 2b) . The surgical margin of the corneal site was not free of tumor cells. Topical interferon (IFN) alfa-2b eyedrops were used as postoperative adjunct therapy 4 times a day for 2 months. On June 5, 2013, a biopsy was conducted from the corneal limbus where the tumor had been. Since the histology revealed no tumor cells, topical IFN eyedrop treatment was stopped. The patient was well without local recurrence of tumor or distal metastases up to December 2015.
Discussion
There are two possibilities of pathogenesis of CIS in this case: CIS may have arisen from the primary pterygium or it may have occurred de novo near the pterygium, subsequently inducing progression of the primary pterygium. In the latter case, there are some unique observations regarding the coincidence of CIS with pterygium: clinically, our patient had frequently been under observation by an ophthalmologist due to glaucoma, and the whitish lesion had initially been observed at the upper side of the primary pterygium, which developed CIS later. IA displayed that blood vessels originating from the primary pterygium spread to the whitish tumor. Moreover, histologically, intraepithelial carcinoma tissue was present together with squamous metaplasia consistent with pterygium. Moreover, this case showed marked inflammatory cell infiltration within the cancer tissue as well as within the subepithelial stroma. Therefore, we would like to diagnose the tumor as 'inflamed CIS' in this case. Although the CIS observed in this case has a close relationship to the primary pterygium based on histological and angiographic examination, it might be hard to determine whether the CIS really arose from the primary pterygium.
As treatment for CIS, complete resection is recommended conventionally [7, 8] . In recent years, local chemotherapy with IFN alfa-2b has been useful as an adjunctive therapy to surgical resection of CIS [7] . In our case, since histologically the corneal margin of the resected tumor was not free of tumor cells, topical IFN alfa-2b was added for 2 months following the surgery. Indeed, the histological examination proved no tumor cells in the biopsy specimens. Additional treatments were not required during the follow-up period of approximately 54 months after the surgery. In conclusion, we showed a rare case of inflamed CIS arising from a primary pterygium which was treated with surgical resection as well as postoperative topical IFN care. Because CIS can occur adjacent to pterygial tissues, long-term follow-up is necessary in patients with pterygia. 
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